NEXGEL, INC.·4

May 29, 8:03 PM ET

Levy Adam R. 4

Research Summary

AI-generated summary

Updated

NEXGEL (NXGL) CEO Adam R. Levy Sells 13,000 Shares

What Happened
Adam R. Levy, CEO of NEXGEL, Inc. (NXGL), sold a total of 13,000 shares of common stock in open‑market transactions between May 27 and May 29, 2026. The filing reports proceeds of approximately $7,835 across three trades: 3,000 shares on 2026‑05‑27 (≈$0.5975/share, $1,793), 7,000 shares on 2026‑05‑28 (weighted average price reported in the filing; listed as $0.61/share, $4,241), and 3,000 shares on 2026‑05‑29 (≈$0.6003/share, $1,801). These were sales (transaction code S), which are commonly routine insider transactions.

Key Details

  • Transaction dates and prices:
    • 2026‑05‑27: 3,000 shares sold at $0.5975 per share (Footnote F1) — ~$1,793
    • 2026‑05‑28: 7,000 shares sold at a weighted average within $0.5958–$0.6133; filing shows $0.61/share (Footnote F2) — ~$4,241
    • 2026‑05‑29: 3,000 shares sold at $0.6003 per share (Footnote F3) — ~$1,801
  • Total sold: 13,000 shares for aggregate proceeds of about $7,835.
  • Shares owned after transaction: Not specified in the excerpt provided.
  • Footnotes of note:
    • F1 and F3 give per‑trade exact prices for the 3,000‑share lots.
    • F2 states the 7,000‑share sale price is a weighted average across multiple prices and the filer will provide a breakdown if requested by the SEC, issuer, or a security holder.
  • Filing timeliness: Form 4 was filed on 2026‑05‑29 covering trades on May 27–29; this appears to be filed within the usual SEC two‑business‑day window.

Context
Sales by executives can be for many reasons (diversification, liquidity, taxes) and do not on their own prove a change in outlook. There were no purchases or option exercises in this filing to indicate a direct bullish signal.